English | Español

Biospace
+ Pharmaceuticals
Patient Daily | Dec 19, 2025

Pfizer CEO criticizes HHS vaccine stance amid declining revenues
+ Pharmaceuticals
Patient Daily | Dec 19, 2025

Kyverna’s CAR T therapy shows strong results for stiff person syndrome
+ Pharmaceuticals
Patient Daily | Dec 19, 2025

Johnson & Johnson receives FDA priority voucher for multiple myeloma drug combination
+ Pharmaceuticals
Patient Daily | Dec 19, 2025

FDA approves first-line use of Enhertu for metastatic HER2-positive breast cancer
+ Pharmaceuticals
Patient Daily | Dec 19, 2025

Ambros raises $125M to bring Italian non-opioid pain drug to U.S. market
+ Pharmaceuticals
Patient Daily | Dec 19, 2025

Sanofi partners with South Korea's ADEL in $1B+ Alzheimer's drug development deal
+ Pharmaceuticals
Patient Daily | Dec 19, 2025

Analysts identify six biotechs as potential big pharma acquisition targets
+ Pharmaceuticals
Patient Daily | Dec 19, 2025

Lilly posts strong weight loss trial results; FDA denies black box plan for COVID vaccines

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation